Efficacy of broad-spectrum sunscreens against the suppression of elicitation of delayed-type hypersensitivity responses in humans depends on the level of ultraviolet A protection

Experimental Dermatology

Volumn 12, Issue 2, 2003, Pages 153-159

  Moyal, Dominique D ^a   Fourtanier, A M ^a  

^a Applied Research Laboratories   (France)

Author keywords

Acute UV exposure; Delayed type hypersensitivity elicitation; SPF; Sunscreens; UVA protection

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ANTIGEN; AVOBENZONE; OCTOCRYLENE; SALICYLIC ACID OCTYL ESTER; SUNSCREEN; UNCLASSIFIED DRUG; ZINC OXIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; ERYTHEMA; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; SOLAR RADIATION; SPECTRUM; SUN EXPOSURE; SUNLIGHT PROTECTION; ULTRAVIOLET A RADIATION; VOLUNTEER;

ADOLESCENT; ADULT; ANTIGENS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; MALE; SUNBURN; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 0043175196     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2003.00020.x     Document Type: Article

References (21)

1. Whitmore S E, Morison W L. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermatol 1995: 131: 1128-1133.
2. Serre I, Cano J P, Picot M C, Meynadier J, Meunier L. Immunosuppression induced by acute solar-simulated ultraviolet exposure in humans: Prevention by a sunscreen with a sun protection factor of 15 and high UVA protection. J Am Acad Dermatol 1997: 37: 187-194.
3. Bestak P, Barnetson R S C, Nearn M R, Halliday G M. Sunscreen protection of contact hypersensitivity. Responses from chronic solar simulated ultraviolet irradiaton correlates with the absorption spectrum of the sunscreen. J Invest Dermatol 1995: 105: 345-351.
4. Damian D L, Halliday G M, Taylor C A, Barnetson R S C. Broadspectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 1997: 109: 146-151.
5. Gueniche A, Fourtanier A. Mexoryl SX protects against photoimmunosuppression. In: Altmeyer P, Hoffmann K, Stucker M, eds. Skin Cancer and UV Radiation. Berlin: Springer-Verlag, 1997: 249-262.
6. Moyal D, Courbiere C, Le Corre Y, Lacharriere O, Hourseau C. Immunosuppression induced by chronic solar-simulated irradiation in humans and its prevention by sunscreens. Eur J Dermatol 1997: 7: 223-225.
7. Fourtanier A, Gueniche A, Compan D, Walker S, Young A. Improved protection against solar-simulated radiation-induced immunosuppression by a sunscreen with enhanced ultraviolet a protection. J Invest Dermatol 2000: 114: 620-627.
8. Moyal D. Immunosuppression induced by chronic ultraviolet irradiation in humans and its prevention by sunscreens. Eur J Dermatol 1998: 8: 209-211.
9. Moyal D, Fourtanier A. Broadspectrum sunscreens provide better protection from the solar UV simulated radiation and natural sunlight-induced immunosuppression in humans. J Invest Dermatol 2001: 117: 1186-1192.
10. Damian D L, Barnetson R S C, Halliday G M. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photobiol 1999: 70: 910-915.
11. Fitzpatrick T B. The validity and practically of sun-reactive skin types I through VI. Arch Dermatol 1988: 124: 869-871.
12. Colipa. Colipa Sun Protection Factor Test Method. Brussels, Belgium: The European Cosmetic, Toiletry and Perfumery Association, 1994.
13. Moyal D, Chardon A, Kollias N. UVA protection efficacy of sunscreens can be determined by the persistent pigment darkening (PPD) method. Photodermatol Photoimmunol Photomed 2000: 16: 250-255.
14. Japan Cosmetic Industry Association (JCIA). Measurements Standard for UVA Protection Efficacy. Tokyo, Japan, 1996.
15. Diffey B L, Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989: 40: 127-133.
16. Kelly D A, Young A R, McGregor J M, Seed P T, Potten C S, Walker S L. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 2000: 191: 561-566.
17. Wolf P, Hoffmann C, Grinschgl S, Quehenberger F, Kerl H. Human in vivo immune protection factors of sunscreens containing chemical UV filters measured in UV dose-response studies in the local contact hypersensitivity model. 62nd Annual Meeting of the Society for Investigative Dermatology, Washington DC, May 9-12, 2001 (Abstract). J Invest Dermatol 2001: 117: 499.
18. Damian D L, Halliday G M, Taylor C A, Barnetson R S C. Ultraviolet radiation induced suppression of Mantoux reactions in humans. J Invest Dermatol 1998: 110: 824-827.
19. Reeve V E, Bosnic M, Boehm-Wilcox C, Nishimura N, Ley R D. Ultraviolet A radiation (320-400 nm) protects hairless mice from immunosuppression induced by ultraviolet B radiation (280-320 nm) or cis-urocanic acid. Int Arch Allergy Immunol 1998: 115: 316-322.
20. Roberts L K, Beasley D G. Commercial sunscreen lotions prevent ultraviolet-radiation-induced immune suppression of contact hypersensitivity. J Invest Dermatol 1995: 105: 339-344.
21. Roberts L K, Beasley D G. Sunscreens prevent local and systemic immunosuppression of contact hypersensitivity in mice exposed to solar-simulated ultraviolet radiation. J Photochem Photobiol B Biol 1997: 39: 121-129.